Skip to content

Decision Counseling Program in Increasing Shared Decision Making and Clinical Trial Participation in Patients With Stage 0-IV Lung Cancer (Free to Breathe)

Increasing Shared Decision Making and Patient Participation in Lung Cancer Clinical Trials (Free to Breathe)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03820557
Enrollment
44
Registered
2019-01-29
Start date
2017-08-03
Completion date
2020-03-28
Last updated
2025-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Brief summary

This clinical trial studies how well the Decision Counseling Program works in increasing patient-physician shared decision making and participation in clinical trials for lung cancer patients. Decision aids help provide patients with information that may help them select a course of action related to their cancer care when more than one alternative is available. It also encourages shared decision making allowing patients and their providers to make health decisions together. Determining how patients make decisions about participating in a clinical trial may help doctors facilitate patient decision making and improve participation in lung cancer clinical trials.

Detailed description

PRIMARY OBJECTIVES: I. Facilitate patient deliberation about participation in a lung cancer clinical trial using the Decision Counseling Program (DCP). SECONDARY OBJECTIVES: I. Document the extent to which patient values and preferences are incorporated into physician-patient shared decision making (SDM) about cancer clinical trials. II. Assess changes in patient knowledge, anxiety, and decisional conflict related to clinical trial participation. III. Characterize patient and physician experience with intervention exposure.

Interventions

OTHEREducational Intervention

Undergo Decision Counseling Program

Sponsors

Sidney Kimmel Cancer Center at Thomas Jefferson University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients diagnosed with lung cancer (Stages 0, 1, 2, 3, 4) * Lung cancer patients for which there is an available interventional clinical trial open at Jefferson Kimmel Cancer Center * Patients being treated by a lung medical oncologist on the Center City Campus of Thomas Jefferson University * Able to provide informed consent * English-speaking

Exclusion criteria

* Inability to communicate in English * Unable to provide informed consent * Not eligible for an open, actively accruing interventional trial at Jefferson

Design outcomes

Primary

MeasureTime frameDescription
Patient perception related to clinical trials participation, measured by follow up survey questionsBaseline to 30 daysWill compute descriptive statistics for all sections and determine the variables on which to compare patient responses at the two time points (baseline and endpoint) using paired t-tests.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026